Vaccine Free

The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization.

A study on the effects of vaccination on children and why they may not be necessary.

This book provides parents with a comprehensive, evidence-based guide to the facts, myths, problems and solutions associated with raising a vaccine free child. It helps parents protect their children both from the wiles of the vaccine industry and from harmful germs. It explains the difference between childhood diseases and the other infectious diseases, which is the key to understanding immunisation. Modern medicine fails to recognise that childhood diseases are self-resolving, and prescribes interventions that increase the risk of complications. Raising a Vaccine Free Child explains why self-resolving diseases, like measles and mumps, do not need intervention, but do need proper care to prevent complications from developing. It also advises parents on how to bring children safely through childhood diseases, and discusses the prevention and treatment of the malevolent infectious diseases that are not self-resolving, such as polio and tetanus. Raising a Vaccine Free Child discusses the toxic ingredients and biological contaminants in vaccines, and the relationship between vaccination and the global epidemic of chronic disease. It also helps parents cope with aggression from individuals, and with intimidation from the medical authorities. There is a detailed chapter on ¿herd immunity¿, which empowers parents to withstand the accusation that vaccine free children pose a threat to others. Raising a Vaccine Free Child provides an insight into the workings of the vaccine industry, and into the role of the media in perpetuating myths about vaccination and infectious diseases. It shows that the long-term side effects of vaccination have not been properly assessed at any time in any country. Readers will learn that vaccination is not the reason for the absence of some infectious diseases, and that insidious, long-term side effects of vaccination are common. A look at the history of vaccination reveals that it is an unscientific procedure that is based on falsehood, cruelty and supposition.

The Public Health Foundation (PHF) in partnership with the Centers for Disease Control and Prevention (CDC) is pleased to announce the availability of Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition or “The Pink Book” E-Book. This resource provides the most current, comprehensive, and credible information on vaccine-preventable diseases, and contains updated content on immunization and vaccine information for public health practitioners, healthcare providers, health educators, pharmacists, nurses, and others involved in administering vaccines. “The Pink Book E-Book” allows you, your staff, and others to have quick access to features such as keyword search and chapter links. Online schedules and sources can also be accessed directly through e-readers with internet access. Current, credible, and comprehensive, “The Pink Book E-Book” contains information on each vaccine-preventable disease and delivers immunization providers with the latest information on: Principles of vaccination General recommendations on immunization Vaccine safety Child/adult immunization schedules International vaccines/Foreign language terms Vaccination data and statistics The E-Book format contains all of the information and updates that are in the print version, including: · New vaccine administration chapter · New recommendations regarding selection of storage units and temperature monitoring tools · New recommendations for vaccine transport · Updated information on available influenza vaccine products · Use of Tdap in pregnancy · Use of Tdap in persons 65 years of age or older · Use of PCV13 and PPSV23 in adults with immunocompromising conditions · New licensure information for varicella-zoster immune globulin Contact [email protected] for more information. For more news and specials on immunization and vaccines visit the Pink Book's Facebook fan page

This manual provides the information necessary for successful homoeopathic treatment and prevention of many common infectious contagious diseases. Beyond that, the information herein provides an avenue for the treatment of disease without the use of vaccination. Often the decision not to vaccinate is backed by a mere 'hunch' or 'gut feeling' that vaccination may not be good for oneself or our children. Armed with the knowledge of homeopathy, not only will one be able to successfully treat the disease in question, but also the decision not to vaccinate will be validated by the wealth of information presented in these chapters. Overview Introduction to homeopathic philosophy Some of the adverse effects of vaccination on the immune system Homeopathic treatment of vaccine injury Individual chapters pertaining to the symptom development of infectious contagious disease Recommendations for homeopathic prevention and treatment for each disease

In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.

The Studies the CDC Refuses to Do This book is based on over one hundred studies in the peer-reviewed literature that consider vaccinated versus unvaccinated populations. Each study is analyzed, and health differences among infants, children, and adults who have been vaccinated and those who have not are presented and put in context. Readers will find information on: The infant/child vaccination schedule Thimerosal in vaccines Live virus vaccines The human papillomavirus (HPV) vaccine Vaccination and Gulf War illness Influenza (flu) vaccines Hepatitis B vaccination The COVID-19 vaccine Vaccines during pregnancy Given the massive push to vaccinate the entire global population, this book is timely and necessary for individuals to make informed choices for themselves and their families.

This book is an indispensable tool for anyone involved in the research, development, or manufacture of new or existing vaccines. It describes a wide array of analytical and quality control technologies for the diverse vaccine modalities. Topics covered include the application of both classical and modern bio-analytical tools; procedures to assure safety and control of cross contamination; consistent biological transition of vaccines from the research laboratory to manufacturing scale; whole infectious attenuated organisms, such as live-attenuated and inactivated whole-cell bacterial vaccines and antiviral vaccines using attenuated or inactivated viruses; principles of viral inactivation and the application of these principles to vaccine development; recombinant DNA approaches to produce modern prophylactic vaccines; bacterial subunit, polysaccharide and glycoconjugate vaccines; combination vaccines that contain multiple antigens as well as regulatory requirements and the hurdles of licensure.